Dividends of Novartis AG (id:12977 NOVN)
Comperitors' Dividend Yield
Company | Market Cap USD | Dividend yield | Payout ratio | CAGR 3 years | CAGR 5 years | ||
---|---|---|---|---|---|---|---|
Eli Lilly & | 715.22B | 0.690 % | 54.20 % | 4.63 % | 8.54 % | ||
Johnson & Johnson | 368.63B | 3.24 % | 80.33 % | -4.10 % | -0.170 % | ||
AbbVie | 296.46B | 3.70 % | 213.59 % | 7.84 % | 10.52 % | ||
Merck & | 244.26B | 3.16 % | 64.44 % | 6.08 % | 8.26 % | ||
Roche Holding AG | 238.42B | 15.29 % | 72.51 % | 1.82 % | 2.74 % | ||
Novartis AG | 205.68B | 14.42 % | 65.52 % | 2.75 % | 2.71 % | ||
AstraZeneca PLC | 201.24B | 3.10 % | 72.14 % | 2.79 % | 3.04 % | ||
Amgen | 149.84B | 3.13 % | 113.41 % | 10.01 % | 10.04 % | ||
Pfizer | 140.88B | 6.74 % | 222.67 % | -22.68 % | 3.82 % | ||
Sanofi | 124.06B | 16.55 % | 104.74 % | 4.16 % | 3.28 % |
Boxes
Dividend Yield
14.42 %
Payout Ratio
65.52 %
Compound average growth rate 3 years
2.75 %
Dividend Increase Track Record
26 Years
Latest Dividend
March 11th, 2024
Ex-Dividend Date
March 07th, 2024
Payout frequency
Yearly
Dividend Yield vs Market (countryid: 153, industryId: 134, sectorId: 19 )
Payout Ratio vs Market
Dividend Yield Range
Yield on cost
Dividend payout history
Dividend yield history
Dividend history
Year | Amount | Type | Date |
---|---|---|---|
2024 | 3.30 | Regular | 03-07-2024 |
2023 | 3.20 | Regular | 03-09-2023 |
2022 | 3.10 | Regular | 03-08-2022 |
2021 | 3.00 | Regular | 03-04-2021 |
2020 | 2.95 | Regular | 03-03-2020 |
2019 | 2.85 | Regular | 03-04-2019 |
2018 | 2.80 | Regular | 03-06-2018 |
2017 | 2.75 | Regular | 03-02-2017 |
2016 | 2.70 | Regular | 02-25-2016 |
2015 | 2.60 | Regular | 03-03-2015 |
2014 | 2.45 | Regular | 02-27-2014 |
2013 | 2.30 | Regular | 02-26-2013 |
2012 | 2.25 | Regular | 02-27-2012 |
2011 | 2.20 | Regular | 02-24-2011 |
2010 | 2.10 | Regular | 03-02-2010 |
2009 | 2.00 | Regular | 02-27-2009 |
2008 | 1.60 | Regular | 02-29-2008 |
2007 | 1.35 | Regular | 03-09-2007 |
2006 | 1.15 | Regular | 03-03-2006 |
2005 | 1.05 | Regular | 03-04-2005 |
2004 | 1.00 | Regular | 02-27-2004 |
2003 | 0.950 | Regular | 03-07-2003 |
2002 | 0.900 | Regular | 03-26-2002 |
2001 | 0.850 | Regular | 03-27-2001 |
2000 | 0.800 | Regular | 04-17-2000 |
1999 | 0.725 | Regular | 04-26-1999 |
1998 | 0.625 | Regular | 04-24-1998 |
1997 | 0.500 | Regular | 04-25-1997 |
DividendIncreaseOrDecrease
Dividend table
Chowder Number | 17.12 % (Good, because Chowder number is larger than 15%) |
Compound Average Growth Rate for last 3 years cal | 2.75 % |
Compound Average Growth Rate for last 3 years | 2.75 % |
Compound Average Growth Rate for last 5 years | 2.71 % |
Compound Average Growth Rate for last 10 years | 3.36 % |
Dividend growth | 26 years |
Dividend growth average for all Drug Manufacturers General stocks | 6.77 years (22 stocks) |
Dividend growth average for Switzerland Drug Manufacturers General stocks | 26.50 years (2 stocks) |
forward_annual_dividend_rate | 13.20 CHF |
forward_annual_dividend_yield | 14.42 % |
forward_annual_dividend_yield average for all Drug Manufacturers General stocks | 6.59 % (22 stocks) |
forward_annual_dividend_yield average for Switzerland Drug Manufacturers General stocks | 14.85 % (2 stocks) |
trailing_annual_dividend_rate | 3.92 CHF |
trailing_annual_dividend_yield | 4.27 % |
trailing_annual_dividend_yield average for all Drug Manufacturers General stocks | 0.023 % (22 stocks) |
trailing_annual_dividend_yield average for Switzerland Drug Manufacturers General stocks | 0.039 % (2 stocks) |
5_year_average_dividend_yield | 3.66 % |
5_year_average_dividend_yield average for all Drug Manufacturers General stocks | 3.09 % (22 stocks) |
5_year_average_dividend_yield average for Switzerland Drug Manufacturers General stocks | 3.40 % (2 stocks) |
payout_ratio | 65.52 % |
payout_ratio average for all Drug Manufacturers General stocks | 221.58 % (22 stocks) |
payout_ratio average for Switzerland Drug Manufacturers General stocks | 69.01 % (2 stocks) |
dividend_date | 03-11-2024 |
ex_dividend_date | 03-07-2024 |
Self funded chart
Years before free
Years before free | 0 |
Year free | 2024 |
Self funded table
Year number | Year | Sum |
---|---|---|
1 | 2025 | 3.92 |
2 | 2026 | 7.94 |
3 | 2027 | 12.08 |
4 | 2028 | 16.32 |
5 | 2029 | 20.68 |
6 | 2030 | 25.16 |
7 | 2031 | 29.76 |
8 | 2032 | 34.49 |
9 | 2033 | 39.34 |
10 | 2034 | 44.32 |
11 | 2035 | 49.44 |
12 | 2036 | 54.70 |
13 | 2037 | 60.10 |
14 | 2038 | 65.65 |
15 | 2039 | 71.34 |
16 | 2040 | 77.19 |
17 | 2041 | 83.20 |
18 | 2042 | 89.37 |
19 | 2043 | 95.71 |
DividentYearsScore: 100
Dividened Top table
Roche Holding AG | 27 |
Novartis AG | 26 |
AVG | 26.5 |
Dividened Bottom table
Bayer AG | 1 |
Cosmo Pharmaceuticals N.V. | 1 |
AVG | 1 |
FAQ
Yes, Novartis AG pays a dividend. The dividend was last paid on the March 11th, 2024.
The last dividend paid by Novartis AG was CHF 3.92 per share on March 11th, 2024.
Novartis AG next scheduled ex-dividend date is March 07th, 2024.
Novartis AG has been paying dividends for the past 2 years.
No, Novartis AG does not have a history of special dividend payouts.
The payout ratio of Novartis AG is 65.52%, meaning that 65.52% of the profits are paid out as dividends.
Novartis AG dividend payout ratio of 65.52% is below the industry average of 221.58%.